1. "Clinical Genetics Service"
Formats
  1. Journal Article (708)
  2. Meeting Abstract (340)
  3. Review (20)
  4. Book Section (10)
  5. Guidelines (8)
  6. Editorial (7)
  7. Research Letter (6)
  8. Conference Paper (5)
  9. Correspondence (4)
  10. Book Whole (1)
  11. Miscellaneous (1)
Groups
  1. Clinical Genetics Service (1110)
  2. Department of Medicine (1110)
  3. Population Sciences Research Program (1110)
  4. Solid Tumor Oncology Division (1110)
  5. Survivorship Research (930)
  6. GSK Faculty (897)

More Groups

People
  1. Kenneth Offit (788)
  2. Zsofia Stadler (390)
  3. Mark Robson (297)
  4. Vijai Joseph (211)
  5. Michael Walsh (156)
  6. Jinru Shia (134)

More People

Years
  1. 2025 (13)
  2. 2024 (46)
  3. 2023 (68)
  4. 2022 (69)
  5. 2021 (71)
  6. 2020 (76)

More Years

Publications
  1. Journal of Clinical Oncology (188)
  2. Cancer Research (59)
  3. Blood (42)
  4. American Journal of Human Genetics (32)
  5. Clinical Cancer Research (32)
  6. Genetics in Medicine (28)

More Publications

Publishers
  1. American Society of Clinical Oncology (216)
  2. Nature Publishing Group (140)
  3. American Association for Cancer Research (125)
  4. Elsevier Inc. (64)
  5. Oxford University Press (63)
  6. Springer (60)

More Publishers

Results (1110)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Absence of loss of heterozygosity of BRCA1 in a renal tumor from a BRCA1 germline mutation carrier
    Journal Article

    Alanee, S.; Shah, S.; Murali, R.; Rau-Murthy, R.; Schrader, K. A.; Offit, K.
    Familial Cancer (2013)

    Fulltext@MSK | Save
  • Secondary mutation in a coding mononucleotide tract in MSH6 causes loss of immunoexpression of MSH6 in colorectal carcinomas with MLH1/PMS2 deficiency
    Journal Article

    Shia, J.; Zhang, L.; Shike, M.; Guo, M.; Stadler, Z.; Xiong, X.; Tang, L. H.; Vakiani, E.; Katabi, N.; Wang, H.; more...
    Modern Pathology (2013)

    Fulltext@MSK | Save
  • Single nucleotide polymorphisms as markers of bacillus Calmette-Guerin intravesical therapy response in non-muscle invasive bladder cancer
    Meeting Abstract

    Alanee, S.; Hamilton, R. J.; Joseph, V.; Ostrovnaya, I.; Garcia-Grossman, I. R.; Gallagher, D. J.; Pendse, D.; Regazzi, A. M.; Przybylo, J. A.; Gaudet, M.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Association of single-nucleotide polymorphisms in BCL2L1 and TACC3 with response to bacillus Calmette-Guerin intravesical therapy in non-muscle-invasive bladder cancer
    Meeting Abstract

    Alanee, S.; Gallagher, D. J.; Vijai, J.; Hamilton, R. J.; Ostrovnaya, I.; Garcia-Grossman, I. R.; Riches, J. C.; Regazzi, A. M.; Przybylo, J. A.; Gaudet, M.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Phase II study of ganetespib, an hsp-90 inhibitor, in patients with refractory metastatic colorectal cancer
    Meeting Abstract

    Cercek, A.; Shia, J. R.; Gollub, M.; Raasch, P. J.; Hollywood, E.; Reidy, D. L.; Janjigian, Y. Y.; Stadler, Z. K.; Segal, N. H.; O'Reilly, E. M.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • SLX4 mutation in hereditary breast cancer
    Meeting Abstract

    Shah, S.; Lach, F.; Kim, Y.; Sarrel, K.; Rau-Murthy, R.; Hansen, N.; Rendleman, J.; Kirchhoff, T.; Joseph, V.; Offit, K.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Attitudes of metastatic breast cancer patients towards research biopsies
    Meeting Abstract

    Seah, D. S.; Scott, S. M.; Najita, J.; Openshaw, T.; Krag, K. J.; Frank, E.; Sohl, J.; Stadler, Z. K.; Garrett, M.; Winer, E. P.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save
  • The prevalence of thyroid cancer and benign thyroid disease in patients with familial adenomatous polyposis may be higher than previously recognized
    Journal Article

    Steinhagen, E.; Guillem, J. G.; Chang, G.; Salo-Mullen, E. E.; Shia, J.; Fish, S.; Stadler, Z. K.; Markowitz, A. J.
    Clinical Colorectal Cancer (2012)

    Fulltext@MSK | Save
  • Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers
    Journal Article

    Antoniou, A. C.; Kuchenbaecker, K. B.; Soucy, P.; Beesley, J.; Chen, X.; McGuffog, L.; Lee, A.; Barrowdale, D.; Healey, S.; Sinilnikova, O. M.; more...
    Breast Cancer Research (2012)

    Fulltext@MSK | Save
  • The KL-VS sequence variant of Klotho and cancer risk in BRCA1 and BRCA2 mutation carriers
    Journal Article

    Laitman, Y.; Kuchenbaecker, K. B.; Rantala, J.; Hogervorst, F.; Peock, S.; Godwin, A. K.; Arason, A.; Kirchhoff, T.; Offit, K.; Isaacs, C.; more...
    Breast Cancer Research and Treatment (2012)

    Fulltext@MSK | Save